Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02251379 · ClinicalTrials.gov registry record · Phase 2
Environmental Control as Add-on Therapy in Childhood Asthma
A Phase 2 study of Asthma, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 2
- Development phase
- 155
- Enrollment target
- 1
- Study location
NCT02251379: Completed Phase 2 study of Asthma, sponsored by Johns Hopkins University.
NCT02251379 is a Phase 2 study of Asthma that has completed, run by Johns Hopkins University. The registered enrollment target is 155 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02251379, a Phase 2 study of Asthma, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 155 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the effects of adding on an environmental home intervention to standard asthma medication management on controller medication requirements among children and adolescents with asthma. The investigators hypothesize that the addition of an individually-tailored, multi-faceted Environmental Control Strategy (ECS) to guidelines-based controller medication will result in less controller medication requirement and allergic inflammation than controller medication alone among urban asthmatic children.
Conditions Studied
Interventions
- DRUG Advair Diskus
- DRUG Flovent Diskus
- OTHER Home Environmental Intervention
Study Locations (1)
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2014-10-01 |
| Est. Completion | 2018-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02251379
The ClinicalTrials.gov registry entry for NCT02251379 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 155 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (90% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 3 interventions - of which Advair Diskus is the first listed.
NCT02251379 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT02251379 about?
NCT02251379 is a clinical study titled "Environmental Control as Add-on Therapy in Childhood Asthma". This study evaluates the effects of adding on an environmental home intervention to standard asthma medication management on controller medication requirements among children and adolescents with asthma. The investigators hypothesize that the addition of an individually-tailored, multi-faceted Envir...
What is the current status of trial NCT02251379?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 155 participants. The study started on 2014-10-01. Estimated completion is 2018-11.
What conditions does trial NCT02251379 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT02251379?
The interventions under investigation include: Advair Diskus (DRUG), Flovent Diskus (DRUG), Home Environmental Intervention (OTHER).
Who is sponsoring clinical trial NCT02251379?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02251379 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
RECRUITING · Phase 2
-
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
RECRUITING · Phase 2
-
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
RECRUITING · Phase 2
-
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
RECRUITING · Phase 2
-
Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
RECRUITING · Phase 2
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.